HWHG(SH:600079) 智通财经网·2025-06-27 10:24Group 1 - The controlling shareholder of Renfu Pharmaceutical, Wuhan Contemporary Technology Industry Group, has received court approval for its restructuring plan on April 25, 2025 [1] - As of June 27, 2025, the transfer of 387 million shares of Renfu Pharmaceutical from Contemporary Technology to the new shareholders has been completed, with the transfer date being June 26, 2025 [1] - After the share transfer, Zhaoshang Biomedical directly holds 97.93 million shares of Renfu Pharmaceutical, accounting for 6% of the total share capital [1] Group 2 - Zhaoshang Biomedical has obtained the corresponding partnership interests from the limited partnership, and the trust plan Spring Mud No. 1 has delegated its voting rights of 11.70% of the shares to Zhaoshang Biomedical [2] - As of the announcement date, Zhaoshang Biomedical controls a total of 403 million ordinary shares, representing 24.70% of the voting rights of the company [2] - Zhaoshang Biomedical needs to complete the reorganization of the board of directors to establish control, after which the controlling shareholder will change to Zhaoshang Biomedical and the actual controller will change to China Merchants Group [2]